These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38053076)
21. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma. Pavord I; Woodcock A; Parker D; Rice L; Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478 [TBL] [Abstract][Full Text] [Related]
22. lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma. Xu Z; Meng L; Xie Y; Guo W Braz J Med Biol Res; 2020; 53(7):e9271. PubMed ID: 32520202 [TBL] [Abstract][Full Text] [Related]
23. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy. Bukstein DA; Henk HJ; Luskin AT Clin Ther; 2001 Sep; 23(9):1589-600. PubMed ID: 11589270 [TBL] [Abstract][Full Text] [Related]
24. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of efficiency and safety of combined montelukast sodium and budesonide in children with cough variant asthma: A protocol for systematic review and meta-analysis. Tang Q; Lei H; You J; Wang J; Cao J Medicine (Baltimore); 2021 Jun; 100(25):e26416. PubMed ID: 34160429 [TBL] [Abstract][Full Text] [Related]
26. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Katial RK; Oppenheimer JJ; Ostrom NK; Mosnaim GS; Yancey SW; Waitkus-Edwards KR; Prillaman BA; Ortega HG Allergy Asthma Proc; 2010; 31(1):68-75. PubMed ID: 20167147 [TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of strategies for reducing treatment in mild persistent asthma. ; Peters SP; Anthonisen N; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA N Engl J Med; 2007 May; 356(20):2027-39. PubMed ID: 17507702 [TBL] [Abstract][Full Text] [Related]
28. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast. Orsini L; Limpa-Amara S; Crown WH; Stanford RH; Kamal K Ann Allergy Asthma Immunol; 2004 May; 92(5):523-9. PubMed ID: 15191020 [TBL] [Abstract][Full Text] [Related]
30. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy. Allen-Ramey FC; Bukstein D; Luskin A; Sajjan SG; Markson LE J Manag Care Pharm; 2006 May; 12(4):310-21. PubMed ID: 16792437 [TBL] [Abstract][Full Text] [Related]
31. Montelukast and Budesonide for Childhood Cough Variant Asthma. Sun W; Liu HY J Coll Physicians Surg Pak; 2019 Apr; 29(4):345-348. PubMed ID: 30925958 [TBL] [Abstract][Full Text] [Related]
32. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children]. Rely K; McQuire SE; Alexandre PK; Escudero GS Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898 [TBL] [Abstract][Full Text] [Related]
33. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population. Pathak DS; Davis EA; Stanford RH Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555 [TBL] [Abstract][Full Text] [Related]
34. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Stempel DA; Mauskopf J; McLaughlin T; Yazdani C; Stanford RH Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241 [TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast. Stempel DA; Kruzikas DT; Manjunath R J Pediatr; 2007 Feb; 150(2):162-7. PubMed ID: 17236894 [TBL] [Abstract][Full Text] [Related]
36. [Micro-invasive embedding combined with montelukast sodium for children cough variant asthma:a randomized controlled trial]. Wang X; Liu B; Lu B; Zhang Y; Wang L; Li H; Han X; Ding D Zhongguo Zhen Jiu; 2017 Mar; 37(3):259-264. PubMed ID: 29231431 [TBL] [Abstract][Full Text] [Related]
37. [Therapeutic efficacy and follow-up study of inhaled corticosteroids vs. oral montelukast in treatment of cough variant asthma]. Sun LH; Chen AH; Zhang Y Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):85-8. PubMed ID: 19099676 [TBL] [Abstract][Full Text] [Related]
38. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma. Yi F; Zhan C; Liu B; Li H; Zhou J; Tang J; Peng W; Luo W; Chen Q; Lai K Respir Res; 2022 Oct; 23(1):279. PubMed ID: 36217131 [TBL] [Abstract][Full Text] [Related]
39. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related]
40. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Sherman J; Patel P; Hutson A; Chesrown S; Hendeles L Pharmacotherapy; 2001 Dec; 21(12):1464-7. PubMed ID: 11765298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]